Heparin calcium treated Henoch–Schönlein purpura nephritis in children through inhibiting hyperfibrinolysis

References

• Kurdi MS, Deva RS, Theerth KA. An interesting perioperative rendezvous with a case of Henoch–Schonlein purpura. Anesth Essays Res. 2014;8(3):404–406
   Google Scholar
• Johnson EF, Lehman JS, Wetter DA, et al. Henoch–Schonlein purpura and systemic disease in children: Retrospective study of clinical findings, histopathology, and direct immunofluorescence in 34 pediatric patients. Br J Dermatol. 2015;172(5):1358--1363
   PubMed Web of Science ®Google Scholar
• Davin JC, Coppo R. Henoch–Schönlein purpura nephritis in children. Nat Rev Nephrol. 2014;10(10):563–573
   PubMed Web of Science ®Google Scholar
• Pohl M. Henoch–Schönlein purpura nephritis. Pediatr Nephrol. 2015;30(2):245--252
   PubMed Web of Science ®Google Scholar
• Almeida JL, Campos LM, Paim LB, et al. Renal involvement in Henoch–Schönlein purpura: A multivariate analysis of initial prognostic factors. J Pediatr. 2007;83(3):259–263
   Google Scholar
• Alfredo CS, Nunes NA, Len CA, et al. Henoch–Schönlein purpura: Recurrence and chronicity. J Pediatr. 2007;83(2):177–180
   Google Scholar
• Butani L, Morgenstern BZ. Long-term outcome in children after Henoch–Schönlein purpura nephritis. Clin Pediatr. 2007;46(6):505–511
   PubMed Web of Science ®Google Scholar
• Prandota J, Pankow-Prandota L, Kotecki L. Impaired activation of the fibrinolytic system in children with Henoch–Schönlein purpura: Beneficial effect of hydrocortisone plus Sigma-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am J Ther. 2001;8(1):11–19
   PubMedGoogle Scholar
• Matayoshi T, Omi T, Sakai N, et al. Clinical significance of blood coagulation factor XIII activity in adult Henoch–Schönlein purpura. J Nippon Med Sch. 2013;80(4):268–278
   PubMed Web of Science ®Google Scholar
• Xu M, Li XJ, Shi H, et al. Plasma TFPI level in children with Henoch–Schönlein purpura and the effect of low molecular weight heparin therapy. Zhonghua Er Ke Za Zhi. 2004;42(11):860–861
   PubMedGoogle Scholar
• Zaffanello M, Bruqnara M, Franchini M, Fanos V. Adjuvant treatments for Henoch–Schönlein purpura nephritis in children: A systematic review. Curr Ther Res Clin Exp. 2009;70(3):254–265
   PubMed Web of Science ®Google Scholar
• Kaku Y, Nohara K, Honda S. Renal involvement in Henoch–Schönlein purpura: A multivariate analysis of prognostic factors. Kidney Int. 1998;53(6):1755–1759
   PubMed Web of Science ®Google Scholar
• Shorr AF, Trotta RF, Alkins SA, et al. d-Dimer assay predicts mortality in critically ill patients without disseminated intravascular coagulation or venous thromboembolic disease. Intensive Care Med. 1999;25(2):207–210
   PubMed Web of Science ®Google Scholar
• Yilmaz D, Kavakli K, Ozkayin N. The elevated markers of hypercoagulability in children with Henoch–Schönlein purpura nephritis. Pediatr Hematol Oncol. 2005;22(1):41–48
   PubMed Web of Science ®Google Scholar
• Shi D, Xia T, Feng H, Cheng Q. Evaluating the diagnostic value of vWF:Ag, D–D and FDP in patients with acute cerebral infarction using ROC curves. Exp Ther Med. 2014;7(6):1573–1577
   Web of Science ®Google Scholar
• Zajadacz B, Juszkiewicz A. Increased levels of plasma d-dimer in the course of Henoch–Schönlein purpura. Wiad Lek. 2005;58(9–10):581–583
   PubMedGoogle Scholar
• Sillesen M, Johansson PI, Rasmussen LS, et al. Fresh frozen plasma resuscitation attenuates platelet dysfunction compared with normal saline in a large animal model of multisystem trauma. J Trauma Acute Care Surg. 2014;76(4):998–1007
   Google Scholar
• Chan V, Yeung CK, Chan TK. Antithrombin III and fibrinogen degradation product (fragment E) in diabetic nephropathy. J Clin Pathol. 1982;35(6):661–666
   PubMed Web of Science ®Google Scholar
• Moudgil A. Renal venous thrombosis in neonates. Curr Pediatr Rev. 2014;10(2):101–106
   Google Scholar
• Cetin Iİ, Ekici F, Ünal S, et al. Intracardiac thrombus in children: The fine equilibrium between the risk and the benefit. Pediatr Hematol Oncol. 2014;31(5):481–487
   PubMed Web of Science ®Google Scholar
• Pincus KJ, Hynicka LM. Prophylaxis of thromboembolic events in patients with nephritic syndrome. Ann Pharmacother. 2013;47(5):725–734
   PubMed Web of Science ®Google Scholar
• Fukui H, Kamitsuji H, Nagao T, et al. Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch–Schönlein purpura. Japanese Pediatric Group. Thromb Res. 1989;56(6):667–675
   PubMed Web of Science ®Google Scholar
• Hedberg A, Fismen S, Fenton KA, et al. Heparin exerts a dual effect on murine lupus nephritis by enhancing enzymatic chromatin degradation and preventing chromatin binding in glomerular membranes. Arthritis Rheum. 2011;63(4):1065–1075
   PubMed Web of Science ®Google Scholar